Kymera Therapeutics, Inc. (KYMR) has 64 open-market insider trades by 18 insiders since 2021. Over the last six months insiders net sold $174.4M. The most active filer is Nello Mainolfi, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| BVF Partners L P/il | Dir | — | 2 | $181.9M | 2026-06-26 |
| Felix Baker | Dir10% Owner | — | 1 | $172.5M | 2025-12-11 |
| Bruce Booth | Dir | — | 7 | $102.2M | 2026-06-29 |
| Biotechnology Value Trading Fund OS LP via Matthew D. Perry | Dir | — | 2 | $34.6M | 2025-06-30 |
| Baker Bros. Advisors (GP) LLC via Felix Baker | Dir | — | 1 | $28.8M | 2025-06-30 |
| Biotechnology VALUE FUND L P | Dir | — | 2 | $25.7M | 2022-05-20 |
| BVF Inc/il | Dir | — | 2 | $18.4M | 2022-05-06 |
| Nello Mainolfi | CEO | — | 13 | $18.0M | 2026-10-01 |
| Biotechnology VALUE FUND II L.P. | Dir | — | 2 | $16.7M | 2024-08-20 |
| BVF II GP LLC | Dir | — | 1 | $10.6M | 2023-11-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Nello Mainolfi | CEO | Sell | $3.4M | 2026-10-01 |
| Brian Adams | CLO | Sell | $744K | 2026-09-04 |
| Nello Mainolfi | CEO | Sell | $6.0M | 2026-07-07 |
| Nello Mainolfi | CEO | Sell | $9.2M | 2026-07-01 |
| Noah Goodman | — | Sell | $387K | 2026-07-01 |
| Bruce N. Jacobs | CFO | Sell | $8.9M | 2026-06-30 |
Companies that share insiders with KYMR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Bruce Booth | Director | Sell | $3.4M | 2026-06-29 |
| Bruce Booth | Director | Sell | $8.3M | 2026-06-29 |
| Bruce Booth | Director | Sell | $56.5M | 2026-06-26 |
| BVF Partners L P/il | Director | Sell | $173.7M | 2026-06-26 |
| Noah Goodman | — | Sell | $570K | 2026-06-25 |
| Bruce Booth | Director | Sell | $34.8M | 2026-06-25 |
| Bruce Booth | Director | Sell | $44.0M | 2026-06-23 |
| Bruce Booth | Director | Sell | $3.3M | 2026-06-22 |
| Noah Goodman | — | Sell | $248K | 2026-06-22 |